deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT02226497

Telemonitoring Device in Managing Outpatient Care of Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia After Intensive Chemotherapy

Integrating a Telemonitoring Device Into the Outpatient Management of Adult Patients Following Intensive Chemotherapy for MDS and Non-APL AML: A Randomized Pilot Study

Sponsor: Fred Hutchinson Cancer Center

Conditions Acute Myeloid Leukemia Myelodysplastic Syndrome
Interventions Health Telemonitoring Quality-of-Life Assessment Questionnaire Administration Supportive Care
Updated 12 times since 2017 Last updated: Jan 7, 2020 Started: Jan 9, 2015 Primary completion: Aug 30, 2018 Completion: Aug 30, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insufficient staff

Other terminated trials from Fred Hutchinson Cancer Center

See all terminations from Fred Hutchinson Cancer Center

Other Acute Myeloid Leukemia trials with similar outcome

Browse all Acute Myeloid Leukemia trials

Listed as NCT02226497, this NA trial focuses on Acute Myeloid Leukemia and Myelodysplastic Syndrome and remains terminated or withdrawn. Sponsored by Fred Hutchinson Cancer Center, it has been updated 12 times since 2015, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshotRecruiting~Aug 2017 – ~Sep 2017 · 31 days · monthly snapshotRecruiting~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotRecruiting~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshotRecruiting~Jul 2018 – ~Mar 2019 · 8 months · monthly snapshotRecruiting~Mar 2019 – ~Feb 2020 · 11 months · monthly snapshotRecruiting~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshotTerminated~Jan 2021 – ~May 2022 · 16 months · monthly snapshotTerminated~May 2022 – ~Jul 2024 · 26 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

12 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. May 2022 — Jul 2024 [monthly]

    Terminated NA

  4. Jan 2021 — May 2022 [monthly]

    Terminated NA

  5. Feb 2020 — Jan 2021 [monthly]

    Terminated NA

    Status: Recruiting → Terminated

▶ Show 7 earlier versions

  1. Mar 2019 — Feb 2020 [monthly]

    Recruiting NA

  2. Jul 2018 — Mar 2019 [monthly]

    Recruiting NA

  3. Jun 2018 — Jul 2018 [monthly]

    Recruiting NA

  4. Sep 2017 — Jun 2018 [monthly]

    Recruiting NA

  5. Aug 2017 — Sep 2017 [monthly]

    Recruiting NA

  6. Feb 2017 — Aug 2017 [monthly]

    Recruiting NA

  7. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fred Hutchinson Cancer Center
  • National Cancer Institute (NCI)
Data source: Fred Hutchinson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations